Login to Your Account

Sanofi After Genzyme? Stock Soars on Buyout Speculation

By Jennifer Boggs

Monday, July 26, 2010
Rumors of a takeover offer by Sanofi-Aventis SA sent shares of Genzyme Corp. up 15.4 percent Friday, only days after the Cambridge, Mass.-based biotech reported that it was finally getting back on track following last year's manufacturing debacle. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription